Cerebral Physiology of NOWS

计划入组 46 人 · 首次发布于 2026 年 5 月 28 日

Neurostimulation to Improve NOWS Outcomes

计划入组 52 人 · 首次发布于 2021 年 11 月 22 日

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

计划入组 189 人 · 首次发布于 2020 年 1 月 2 日

NORS-8591

NOUS-020

NORS-6491

THINK NOW INCORPORATED

United States

Symptom-Based Opioid Dosing Reduces Hospital Stay for Newborns with Withdrawal Syndrome

Lofexidine Trial Launched for Neonatal Opioid Withdrawal Syndrome

Spark Biomedical Completes Enrollment in Two Pivotal Neurostimulation Trials for Opioid Use Disorder and Neonatal Withdrawal